The Impact of the CB2 Cannabinoid Receptor in Inflammatory Diseases: An Update

被引:8
|
作者
Rakotoarivelo, Volatiana [1 ,2 ]
Mayer, Thomas Z. [1 ,2 ,3 ,4 ]
Simard, Melissa [1 ,2 ]
Flamand, Nicolas [1 ,2 ]
Di Marzo, Vincenzo [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Laval, Ctr Rech Inst, Dept Med, Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1V 4G5, Canada
[2] Univ Laval, Canada Excellence Res Chair Microbiome Endocannabi, Quebec City, PQ G1V 0V6, Canada
[3] Univ Laval, Ecole Nutr, Inst Nutr & Aliments Fonct, Quebec City, PQ G1V 0V6, Canada
[4] Univ Laval, Ecole Nutr, Ctr NUTRISS, Quebec City, PQ G1V 0V6, Canada
[5] Joint Int Unit CNR Italy & Univ Laval, Chem & Biomol Res Microbiome & Its Impact Metab H, Quebec City, PQ G1V 0V6, Canada
来源
MOLECULES | 2024年 / 29卷 / 14期
基金
加拿大健康研究院;
关键词
inflammatory diseases; inflammation; cannabinoid; endocannabinoid; cannabinoid receptor; ACID AMIDE HYDROLASE; ENDOGENOUS LIGAND 2-ARACHIDONOYLGLYCEROL; MONOGLYCERIDE LIPASE DEFICIENCY; INNATE LYMPHOID-CELLS; FATTY LIVER-DISEASE; TYPE-2; RECEPTOR; MURINE MODEL; ENDOCANNABINOID SYSTEM; EXPERIMENTAL COLITIS; NOLADIN ETHER;
D O I
10.3390/molecules29143381
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The emergence of inflammatory diseases is a heavy burden on modern societies. Cannabis has been used for several millennia to treat inflammatory disorders such as rheumatism or gout. Since the characterization of cannabinoid receptors, CB1 and CB2, the potential of cannabinoid pharmacotherapy in inflammatory conditions has received great interest. Several studies have identified the importance of these receptors in immune cell migration and in the production of inflammatory mediators. As the presence of the CB2 receptor was documented to be more predominant in immune cells, several pharmacological agonists and antagonists have been designed to treat inflammation. To better define the potential of the CB2 receptor, three online databases, PubMed, Google Scholar and clinicaltrial.gov, were searched without language restriction. The full texts of articles presenting data on the endocannabinoid system, the CB2 receptor and its role in modulating inflammation in vitro, in animal models and in the context of clinical trials were reviewed. Finally, we discuss the clinical potential of the latest cannabinoid-based therapies in inflammatory diseases.
引用
收藏
页数:36
相关论文
共 50 条
  • [21] Single nucleotide polymorphisms in the cannabinoid CB2 receptor: Molecular pharmacology and disease associations
    Foyzun, Tahira
    Whiting, Maddie
    Velasco, Kate K.
    Jacobsen, Jessie C.
    Connor, Mark
    Grimsey, Natasha L.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (15) : 2391 - 2412
  • [22] Expression of the cannabinoid CB2 receptor in the rat cerebellum: An immunohistochemical study
    Ashton, JC
    Friberg, D
    Darlington, CL
    Smith, PF
    NEUROSCIENCE LETTERS, 2006, 396 (02) : 113 - 116
  • [23] Selective activation of CB2 receptor improves efferocytosis in cultured macrophages
    Jiang, Lisheng
    Chen, Yingmin
    Huang, Xiaojing
    Yuan, Ancai
    Shao, Qin
    Pu, Jun
    He, Ben
    LIFE SCIENCES, 2016, 161 : 10 - 18
  • [24] The CB2 receptor and its role as a regulator of inflammation
    Caroline Turcotte
    Marie-Renée Blanchet
    Michel Laviolette
    Nicolas Flamand
    Cellular and Molecular Life Sciences, 2016, 73 : 4449 - 4470
  • [25] Cannabinoid receptor CB2 ablation protects against TAU induced neurodegeneration
    Galan-Ganga, M.
    Rodriguez-Cueto, C.
    Merchan-Rubira, J.
    Hernandez, F.
    avila, J.
    Posada-Ayala, M.
    Lanciego, J. L.
    Luengo, E.
    Lopez, M. G.
    Rabano, A.
    Fernandez-Ruiz, J.
    Lastres-Becker, I.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2021, 9 (01)
  • [26] Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
    Davis, Mellar P.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (08) : 1123 - 1140
  • [27] Discovery of Homobivalent Bitopic Ligands of the Cannabinoid CB2 Receptor**
    Morales, Paula
    Navarro, Gemma
    Gomez-Autet, Marc
    Redondo, Laura
    Fernandez-Ruiz, Javier
    Perez-Benito, Laura
    Cordomi, Arnau
    Pardo, Leonardo
    Franco, Rafael
    Jagerovic, Nadine
    CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (68) : 15839 - 15842
  • [28] What we know and do not know about the cannabinoid receptor 2 (CB2)
    Malfitano, Anna Maria
    Basu, Sreemanti
    Maresz, Katarzyna
    Bifulco, Maurizio
    Dittel, Bonnie N.
    SEMINARS IN IMMUNOLOGY, 2014, 26 (05) : 369 - 379
  • [29] Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor
    Ndong, Christian
    O'Donnell, Dajan
    Ahmad, Sultan
    Groblewski, Thierry
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 669 (1-3) : 24 - 31
  • [30] CB2 cannabinoid receptors:: new vistas
    Mackie, K.
    Ross, R. A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2008, 153 (02) : 177 - 178